Clinical trial
A Single Dose Of Compound SB-681323 Compared To Prednisolone On A Protein That…
NCT00134693 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00134693 |
|---|---|
| Title | A Single Dose Of Compound SB-681323 Compared To Prednisolone On A Protein That Is an Indicator For Rheumatoid Arthritis |
| Official title | A Randomised, Placebo-controlled, Parallel Group Single Dose Study of SB681323 in Patients With Active RA to Investigate the CRP Dose Response Relationship |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Arthritis, Rheumatoid |
| Intervention type | Drug |
| Interventions | Prednisolone, SB-681323 |
| Enrollment | 77 |
| Start date | Jun 21, 2005 |
| Primary completion | Aug 3, 2006 |
| Completion | Aug 3, 2006 |
| First posted | Aug 25, 2005 |
| Last update posted | Jul 31, 2017 |
| Countries | Australia, France, Germany, Russia, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: